Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
C.12SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
C.12SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
C.12EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
C.12EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
C.12NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
C.12NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.170ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
B.1.170ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
B.1.170SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
B.1.170SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
B.1.170EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.170EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.170NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.170NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.23ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
B.1.23ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
B.1.23SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
B.1.23SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
B.1.23EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.23EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.23NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.23NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.506ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
B.1.1.506ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
B.1.1.506SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
B.1.1.506SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
B.1.1.506EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.506EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.506NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.506NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.6.8ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
B.6.8ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
B.6.8SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
B.6.8SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
B.6.8EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.6.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.6.8NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.6.8NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.438.3ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
B.1.438.3ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
B.1.438.3SWon-SCTACATGCACCAGCAACTGT20502311423133F-20338.9South Korea
B.1.438.3SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
B.1.438.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.438.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.438.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.438.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.27ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
B.1.1.27ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
B.1.1.27SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
B.1.1.27SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used